Buscar
Mostrando ítems 111-120 de 3188
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
(Elsevier, 2022)
Background: Morphine is commonly used to relieve pain, anxiety and dyspnea in STEMI but it lowers blood pressure and delays the activity of oral antiplatelet agents. The impact of morphine on clinical outcomes remains ...
Microsomal epoxide hydrolase genotype and risk of myocardial infarction
(2007)
DNA damage caused by mutagens found in tobacco smoke may contribute to the development of coronary heart disease (CHD). Microsomal epoxide hydrolase (EPHX1) is involved in the metabolism of tobacco smoke mutagens and an ...
Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the Central Valley of Costa Rica
(2004-11)
Arachidonic acid (AA), a precursor of prothrombotic eicosanoids, is potentially atherogenic, but epidemiologic data are scarce. We evaluated the hypothesis that increased AA in adipose tissue is associated with increased ...
Angioplastia primaria en el infarto agudo de miocardio
(Sociedad Uruguaya de Cardiología, 2013)
Targeting the Endothelium to Achieve Cardioprotection
(Frontiers Media, 2021)
Despite considerable improvements in the treatment of myocardial infarction, it is still a highly prevalent disease worldwide. Novel therapeutic strategies to limit infarct size are required to protect myocardial function ...
Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty
(LIPPINCOTT WILLIAMS & WILKINS, 2003)
Objective. To evaluate the effects of glucose-insulin-potassium (GIK) therapy on infarct size and left ventricular function when used as an adjuvant therapy to primary angioplasty.
PKC beta II inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses
(WILEY-BLACKWELL, 2011)
Protein kinase C beta II (PKC beta II) levels increase in the myocardium of patients with end-stage heart failure (HF). Also targeted overexpression of PKC beta II in the myocardium of mice leads to dilated cardiomyopathy ...
Bone marrow cell therapy prevents infarct expansion and improves border zone remodeling after coronary occlusion in rats
(ELSEVIER IRELAND LTD, 2010)
Background: Since the cell therapy benefits for myocardial infarction are mainly related to infarct reduction by regenerating lost myocardium or increasing survival of tissues at risk, we evaluated the effects of bone ...
Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice
(Elsevier Ireland, 2014-11)
Acute myocardial infarction in sickle cell disease: a possible complication of hydroxyurea treatment
(Nature Publishing GroupLondonInglaterra, 2005)